Epclusa 200 mg/50 mg film-coated tablets (sofosbuvir/velpatasvir): supply of Irish product

Due to supply disruption, Gilead has obtained approval from the MHRA to supply Irish product, expected to be on the UK market until 30th June 2021. As there are minor differences in the product information, the UK SPC and PIL should be referred to and the Irish PIL discarded.

Source:

Gilead Sciences Ltd